Pure Global

ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE PÉPTIDO NATRIURÉTICO TIPO B (BNP) HUMANO. - COFEPRIS Registration 1584R2022 SSA

Access comprehensive regulatory information for ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE PÉPTIDO NATRIURÉTICO TIPO B (BNP) HUMANO. (ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE PÉPTIDO NATRIURÉTICO TIPO B (BNP) HUMANO.) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1584R2022 SSA and manufactured by ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.. The device was registered on December 14, 2022.

This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase II
1584R2022 SSA
ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE PÉPTIDO NATRIURÉTICO TIPO B (BNP) HUMANO.
COFEPRIS Analysis ID: 1584R2022 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class / Clase de Riesgo
Clase II
Product Type (Spanish)
III. Agentes de diagnóstico
Product Type (English)
III. Agentes de diagnóstico
Trade Name (Spanish)
ALINITY I BNP
Trade Name (English)
ALINITY I BNP
Registration Information
Analysis ID
1584R2022 SSA
Registration Date
December 14, 2022
Manufacturer / Fabricante
Name (English)
ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.